Key result
The abstract provides background on the burden of pediatric cardiomyopathy, noting an estimated annual incidence of 12,000 to 35,000 cases in the US for those under 19, without presenting trial data.
Why the study?
Does early septal myectomy improve outcomes in children with hypertrophic cardiomyopathy?
Does early septal myectomy improve outcomes in children with hypertrophic cardiomyopathy?
Discusses the justification for early septal myectomy in pediatric hypertrophic cardiomyopathy.
Pediatric cardiomyopathy is a debilitating disease that leads to pump failure and sudden death; in fact, it is the leading cause of heart failure in children (1). Cardiomyopathy and heart failure in infants and children remain serious population health crises for children and their families and confer a great cost burden on society (2-5). In the United States, the estimated annual incidence of congenital cardiovascular malformations or cardiomyopathy in infants, children, and adolescents less than 19 years old is between 12,000 and 35,000 (6).
No takes yet. Share an insight, caveat, or question.
Bansal et al. (2018) conducted an editorial in Pediatric cardiomyopathy. Early septal myectomy was evaluated. The abstract provides background on the burden of pediatric cardiomyopathy, noting an estimated annual incidence of 12,000 to 35,000 cases in the US for those under 19, without presenting trial data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: